A detailed history of Denali Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Denali Advisors LLC holds 5,061 shares of JNJ stock, worth $738,146. This represents 0.09% of its overall portfolio holdings.

Number of Shares
5,061
Holding current value
$738,146
% of portfolio
0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$145.48 - $167.38 $736,274 - $847,110
5,061 New
5,061 $820,000
Q3 2018

Oct 09, 2018

SELL
$121.58 - $142.88 $5.19 Million - $6.1 Million
-42,700 Closed
0 $0
Q2 2018

Jul 11, 2018

BUY
$119.4 - $131.76 $5.1 Million - $5.63 Million
42,700 New
42,700 $5.18 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Denali Advisors LLC Portfolio

Follow Denali Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Denali Advisors LLC with notifications on news.